EP3565592
Meðhöndlun á efnaskiptasjúkdómum með því að hindra mýóstatín-virkni
:
EP einkaleyfi í gildi á Íslandi:
5.1.2018:
1.3.2023:
18701237.2
:
24.4.2023:
15.5.2023
:
4.1.2038:
4.1.2026:
31.1.2026
:
TREATING METABOLIC DISEASES BY INHIBITING MYOSTATIN ACTIVATION
5.1.2018
1.3.2023
24.4.2023
15.5.2023
4.1.2026
:
Scholar Rock, Inc.:
301 Binney Street, 3rd Floor, Cambridge, MA 02142, US
:
DONOVAN, Adriana:
West Roxbury MA 02132, US
:
STRAUB, Michelle:
Yarmouth ME 04096, US
:
WAWERSIK, Stefan:
Westborough MA 01581, US
:
CHYUNG, Yung:
Lexington MA 02421, US
:
WEBSTER, Micah:
Nashua NH 03063, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201762443455 P:
6.1.2017:
US
:
17150586:
6.1.2017:
EP
:
201762530311 P:
10.7.2017:
US
:
201762608069 P:
20.12.2017:
US
:
US2018012686:
5.1.2018
:
A61K 39/395, C07K 16/22, A61P 3/00, A61P 3/04, A61P 3/06, A61P 3/08, A61P 3/10, A61P 5/50, A61P 9/00, A61P 9/10, A61P 21/00, A61P 21/06, A61P 25/00, A61K 39/00, A61P 19/00
: 7
: 30.1.2024
: 4.1.2025
: G.H. Sigurgeirsson ehf.
: 8
: 13.1.2025
: 4.1.2026
: G.H. Sigurgeirsson ehf.